Individualised treatment targets in patients with type-2 diabetes and hypertension
Crossref DOI link:
Published Online: 2018-01-22
Published Print: 2018-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schmieder, Roland E.
Gitt, Anselm K.
Funding for this research was provided by:
Novartis Pharma GmbH, Nürnberg, Germany
25 October 2017
8 January 2018
22 January 2018